Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Docetaxel and Irinotecan in Gastric Cancer [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and irinotecan in gastric/stomach cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression [Phase 2]
Phase 2 clinical trial evaluating disitamab vedotin with sintilimab and XELOX as perioperative treatment for resectable gastric cancer with …
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 clinical trial comparing modified XELOX plus sintilimab versus standard XELOX plus sintilimab as first-line therapy for HER2-negativ…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer [Phase 4]
A phase 4 trial update describing ramucirumab in combination with nab-paclitaxel, lobaplatin, and S-1 as neoadjuvant therapy for advanced ga…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen [Phase 3]
Phase 3 clinical trial update for SHR-A1811 in HER2-positive advanced gastric cancer or gastroesophageal junction adenocarcinoma after progr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial assessing SHR-1210 in combination with capecitabine plus oxaliplatin or apatinib for advanced gastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer [Phase 2]
Phase II study evaluating the combination of Irinotecan, POF (POFI), and tislelizumab in advanced gastric cancer is being investigated.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating Envafolimab in combination with chemotherapy for metastatic or recurrent gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence [Phase 2]
Phase 2 clinical trial comparing postoperative immunotherapy to standard chemotherapy for high-risk gastric cancer after surgery.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating nivolumab in combination with chemotherapy for FGFR2-amplified metastatic gastric cancer with PD-L1 amplification a…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression [Phase 3]
Phase 3 trial investigating RC48-ADC in local advanced or metastatic gastric cancer with HER2 overexpression; status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy [Phase 2, Phase 3]
A trial update on KN026 in combination with chemotherapy for HER2-positive stomach (gastric) cancer patients after failure of first-line the…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating traditional Chinese medicine treatment combined with adjuvant chemotherapy for gastric cancer stages IIIB and III…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]
Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal c…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]
Phase 1 trial evaluating safety and activity of 177Lu-3BP-227 in solid tumours expressing neurotensin receptor type 1; study terminated with…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intraperitoneal paclitaxel with systemic mFOLFOX6 in gastric cancer with peritoneal carcinomatosis has c…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with TS-1 plus either cisplatin or oxaliplatin as first-line therapy for gastric cance…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating perioperative leucovorin, oxaliplatin, docetaxel and S-1 (LOTS) for locally advanced gastric or gastroesop…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation [Phase 2]
Phase II trial update for neoadjuvant laparoscopic HIPEC with chemoradiation in gastric/stomach cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients [Phase 1, Phase 2]
A two-part open-label Phase Ib/II study evaluated varlitinib in combination with weekly paclitaxel for EGFR/HER2 co-expressing advanced or m…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication [Phase 3]
Phase 3 clinical trial assessing eradication of Helicobacter pylori in family members to prevent gastric cancer; currently ACTIVE_NOT_RECRUI…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD [Phase 3]
A Phase 3 trial evaluating whether eradication of Helicobacter pylori affects gastric preneoplastic lesions and neoplasia after endoscopic s…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial investigating taurine combined with sintilimab and chemotherapy for advanced gastric cancer is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial [Phase 3]
Phase 3 clinical trial update for SARONG-II evaluating surveillance after resection of esophageal and gastric cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer [Phase 2]
Phase 2 clinical trial evaluating afatinib plus paclitaxel in advanced HER2-positive, trastuzumab-refractory esophagogastric cancer has comp…